Fecal calprotectin level reflects the severity of Clostridium difficile infection

Jieun Kim, Heejung Kim, Hyun Ju Oh, Hyung Sun Kim, Youn Jee Hwang, Dongeun Yong, Seok Hoon Jeong, Kyungwon Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Clostridium difficile is a significant nosocomial and community-acquired pathogen, and is the leading cause of antibiotic-induced diarrhea associated with high morbidity and mortality. Given that the treatment outcome depends on the severity of C. difficile infection (CDI), we aimed to establish an efficient method of assessing severity, and focused on the stool biomarker fecal calprotectin (FC). FC directly reflects the intestinal inflammation status of a patient, and can aid in interpreting the current guidelines, which requires the integration of indirect laboratory parameters. The distinction of 80 patients with CDI versus 71 healthy controls and 30 severe infection cases versus 50 mild cases was possible using FC as a marker. The area under the receiver operating characteristic curves were 0.821 and 0.746 with a sensitivity of 75% and 70% and specificity of 79% and 80%, for severe versus mild cases, respectively. We suggest FC as a predictive marker for assessing CDI severity, which is expected to improve the clinical management of CDI.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalAnnals of laboratory medicine
Volume37
Issue number1
DOIs
Publication statusPublished - 2017 Jan

Fingerprint

Leukocyte L1 Antigen Complex
Clostridium Infections
Clostridium
Clostridium difficile
Biomarkers
Pathogens
ROC Curve
Anti-Bacterial Agents
Diarrhea
Guidelines
Inflammation
Morbidity
Mortality
Infection

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Kim, Jieun ; Kim, Heejung ; Oh, Hyun Ju ; Kim, Hyung Sun ; Hwang, Youn Jee ; Yong, Dongeun ; Jeong, Seok Hoon ; Lee, Kyungwon. / Fecal calprotectin level reflects the severity of Clostridium difficile infection. In: Annals of laboratory medicine. 2017 ; Vol. 37, No. 1. pp. 53-57.
@article{31ee464d2b29488a86023b41f433bcea,
title = "Fecal calprotectin level reflects the severity of Clostridium difficile infection",
abstract = "Clostridium difficile is a significant nosocomial and community-acquired pathogen, and is the leading cause of antibiotic-induced diarrhea associated with high morbidity and mortality. Given that the treatment outcome depends on the severity of C. difficile infection (CDI), we aimed to establish an efficient method of assessing severity, and focused on the stool biomarker fecal calprotectin (FC). FC directly reflects the intestinal inflammation status of a patient, and can aid in interpreting the current guidelines, which requires the integration of indirect laboratory parameters. The distinction of 80 patients with CDI versus 71 healthy controls and 30 severe infection cases versus 50 mild cases was possible using FC as a marker. The area under the receiver operating characteristic curves were 0.821 and 0.746 with a sensitivity of 75{\%} and 70{\%} and specificity of 79{\%} and 80{\%}, for severe versus mild cases, respectively. We suggest FC as a predictive marker for assessing CDI severity, which is expected to improve the clinical management of CDI.",
author = "Jieun Kim and Heejung Kim and Oh, {Hyun Ju} and Kim, {Hyung Sun} and Hwang, {Youn Jee} and Dongeun Yong and Jeong, {Seok Hoon} and Kyungwon Lee",
year = "2017",
month = "1",
doi = "10.3343/alm.2017.37.1.53",
language = "English",
volume = "37",
pages = "53--57",
journal = "Annals of Laboratory Medicine",
issn = "2234-3806",
publisher = "Seoul National University",
number = "1",

}

Fecal calprotectin level reflects the severity of Clostridium difficile infection. / Kim, Jieun; Kim, Heejung; Oh, Hyun Ju; Kim, Hyung Sun; Hwang, Youn Jee; Yong, Dongeun; Jeong, Seok Hoon; Lee, Kyungwon.

In: Annals of laboratory medicine, Vol. 37, No. 1, 01.2017, p. 53-57.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fecal calprotectin level reflects the severity of Clostridium difficile infection

AU - Kim, Jieun

AU - Kim, Heejung

AU - Oh, Hyun Ju

AU - Kim, Hyung Sun

AU - Hwang, Youn Jee

AU - Yong, Dongeun

AU - Jeong, Seok Hoon

AU - Lee, Kyungwon

PY - 2017/1

Y1 - 2017/1

N2 - Clostridium difficile is a significant nosocomial and community-acquired pathogen, and is the leading cause of antibiotic-induced diarrhea associated with high morbidity and mortality. Given that the treatment outcome depends on the severity of C. difficile infection (CDI), we aimed to establish an efficient method of assessing severity, and focused on the stool biomarker fecal calprotectin (FC). FC directly reflects the intestinal inflammation status of a patient, and can aid in interpreting the current guidelines, which requires the integration of indirect laboratory parameters. The distinction of 80 patients with CDI versus 71 healthy controls and 30 severe infection cases versus 50 mild cases was possible using FC as a marker. The area under the receiver operating characteristic curves were 0.821 and 0.746 with a sensitivity of 75% and 70% and specificity of 79% and 80%, for severe versus mild cases, respectively. We suggest FC as a predictive marker for assessing CDI severity, which is expected to improve the clinical management of CDI.

AB - Clostridium difficile is a significant nosocomial and community-acquired pathogen, and is the leading cause of antibiotic-induced diarrhea associated with high morbidity and mortality. Given that the treatment outcome depends on the severity of C. difficile infection (CDI), we aimed to establish an efficient method of assessing severity, and focused on the stool biomarker fecal calprotectin (FC). FC directly reflects the intestinal inflammation status of a patient, and can aid in interpreting the current guidelines, which requires the integration of indirect laboratory parameters. The distinction of 80 patients with CDI versus 71 healthy controls and 30 severe infection cases versus 50 mild cases was possible using FC as a marker. The area under the receiver operating characteristic curves were 0.821 and 0.746 with a sensitivity of 75% and 70% and specificity of 79% and 80%, for severe versus mild cases, respectively. We suggest FC as a predictive marker for assessing CDI severity, which is expected to improve the clinical management of CDI.

UR - http://www.scopus.com/inward/record.url?scp=85011383098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011383098&partnerID=8YFLogxK

U2 - 10.3343/alm.2017.37.1.53

DO - 10.3343/alm.2017.37.1.53

M3 - Article

C2 - 27834066

AN - SCOPUS:85011383098

VL - 37

SP - 53

EP - 57

JO - Annals of Laboratory Medicine

JF - Annals of Laboratory Medicine

SN - 2234-3806

IS - 1

ER -